Congress mandates pharmacy access to birth control, bans refusals based on belief

What it does

This bill requires pharmacies that stock contraception to dispense FDA-approved birth control and related medications without delay when requested, or to refer customers to another pharmacy or expedite ordering if out of stock. Pharmacies must maintain a non-hostile environment, prevent employee interference, and cannot misrepresent availability or breach confidentiality. Violations trigger civil penalties up to $1,000/day (capped at $100,000 per case) and private lawsuits for damages. The bill carves out refusals based on lack of valid prescription, inability to pay, or genuine clinical judgment—but explicitly bars Religious Freedom Restoration Act defenses.

Why we flagged it

The bill's core mechanism is a direct operational duty imposed on pharmacies—stock and dispense contraception without delay or facilitate access—backed by civil penalties and private litigation. This is a public-health access mandate, not a subsidy, tax provision, or commemorative measure.

What the text implies

• The bill's private cause of action (allowing customers to sue for damages) may generate significant litigation against pharmacy chains and independent pharmacies, potentially raising compliance costs and insurance premiums that could be passed to consumers.
• The 'without delay' standard is tied to 'usual and customary timeframe' for other products, creating ambiguity in enforcement—pharmacies may argue that contraception ordering timelines match other specialty medications, potentially leading to disputes.

The full analysis lists 5 implications of this text.

Who stands to gain

Pharmaceutical manufacturers (increased contraceptive sales volume and consistency); Pharmacy chains (regulatory compliance costs offset by increased customer traffic and contraceptive; Legal services (private litigation and enforcement defense)